FAGRON (FAGR.BR) Stock Price & Overview

EBR:FAGR • BE0003874915

Current stock price

23.95 EUR
-0.35 (-1.44%)
Last:

The current stock price of FAGR.BR is 23.95 EUR. Today FAGR.BR is down by -1.44%. In the past month the price increased by 10.62%. In the past year, price increased by 23.84%.

FAGR.BR Key Statistics

52-Week Range19.24 - 24.5
Current FAGR.BR stock price positioned within its 52-week range.
1-Month Range20.9 - 24.5
Current FAGR.BR stock price positioned within its 1-month range.
Market Cap
1.767B
P/E
19.31
Fwd P/E
15.93
EPS (TTM)
1.24
Dividend Yield
1.18%

FAGR.BR Stock Performance

Today
-1.44%
1 Week
-1.84%
1 Month
+10.62%
3 Months
+5.04%
Longer-term
6 Months +15.14%
1 Year +23.84%
2 Years +31.30%
3 Years +42.05%
5 Years +28.35%
10 Years +276.57%

FAGR.BR Stock Chart

FAGRON / FAGR Daily stock chart

FAGR.BR Stock Screens

FAGR.BR currently appears in the following ChartMill screener lists.

FAGR.BR Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to FAGR.BR. When comparing the yearly performance of all stocks, FAGR.BR turns out to be only a medium performer in the overall market: it outperformed 63.65% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FAGR.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to FAGR.BR. FAGR.BR scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FAGR.BR Earnings

Next Earnings DateJul 30, 2026
Last Earnings DateApr 9, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

FAGR.BR Forecast & Estimates

13 analysts have analysed FAGR.BR and the average price target is 28.49 EUR. This implies a price increase of 18.94% is expected in the next year compared to the current price of 23.95.

For the next year, analysts expect an EPS growth of 15.05% and a revenue growth 18.14% for FAGR.BR


Analysts
Analysts86.15
Price Target28.49 (18.96%)
EPS Next Y15.05%
Revenue Next Year18.14%

FAGR.BR Groups

Sector & Classification

Index Membership

FAGR.BR Financial Highlights

Over the last trailing twelve months FAGR.BR reported a non-GAAP Earnings per Share(EPS) of 1.24. The EPS increased by 12.66% compared to the year before.


Income Statements
Revenue(TTM)952.17M
Net Income(TTM)91.02M
Industry RankSector Rank
PM (TTM) 9.56%
ROA 7.32%
ROE 16.5%
Debt/Equity 0.83
Chartmill High Growth Momentum
EPS Q2Q%11.87%
Sales Q2Q%7.55%
EPS 1Y (TTM)12.66%
Revenue 1Y (TTM)9.2%

FAGR.BR Ownership

Ownership
Inst Owners65.92%
Shares73.77M
Float52.56M
Ins Owners0.3%
Short Float %N/A
Short RatioN/A

About FAGR.BR

Company Profile

FAGR logo image Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 4,297 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.

Company Info

IPO: 2007-10-05

FAGRON

Venecoweg 20A

Nazareth OOST-VLAANDEREN BE

Employees: 4193

FAGR Company Website

FAGR Investor Relations

Phone: 3280012880

FAGRON / FAGR.BR FAQ

Can you describe the business of FAGRON?

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 4,297 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.


What is the stock price of FAGRON today?

The current stock price of FAGR.BR is 23.95 EUR. The price decreased by -1.44% in the last trading session.


Does FAGR stock pay dividends?

FAGRON (FAGR.BR) has a dividend yield of 1.18%. The yearly dividend amount is currently 0.36.


How is the ChartMill rating for FAGRON?

FAGR.BR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Where is FAGRON (FAGR.BR) stock traded?

FAGR.BR stock is listed on the Euronext Brussels exchange.


Can you provide the sector and industry classification for FAGRON?

FAGRON (FAGR.BR) operates in the Health Care sector and the Health Care Providers & Services industry.